PolyPid (PYPD) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
PolyPid Ltd., an Israeli company, is moving forward with a registration statement to sell up to $8.25 million of its ordinary shares under a new sales agreement with Oppenheimer & Co. Inc. This strategic financial move aims to bolster the company’s capital for future growth and operations, an enticing prospect for investors eyeing opportunities in the biotech sector. The shares will be issued and sold as per the terms approved by the company’s board.
For further insights into PYPD stock, check out TipRanks’ Stock Analysis page.
